Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest cardiac arrhythmia Stories

2012-05-10 02:31:56

SAN CLEMENTE, Calif., May 10, 2012 /PRNewswire/ -- Cameron Health, Inc. ("Cameron Health") announced today that the S-ICD® System met the primary safety and efficacy endpoints defined in their 330 patient IDE clinical study. The data were presented at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston, MA by Martin C. Burke, D.O., from the University of Chicago as part of the Late-Breaking Scientific Session. The S-ICD System is the world's first...

2012-05-10 02:31:51

MORRISVILLE, N.C., May 10, 2012 /PRNewswire/ -- Electrophysiology thought leaders gathered to discuss the significance of posterior ablation in the treatment of arrhythmias, with presentations highlighting the importance of isolating the posterior left atrium with an adjunctive epicardial treatment. The symposium was supported by nContact, Inc. and held in conjunction with Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA, on the evening of May 8....

2012-05-09 19:45:46

Older women who have been diagnosed with an irregular heart beat are at higher risk of stroke than men. A new study led by the Research Institute of the McGill University Health Centre (RI MUHC) shows that warfarin, the most common anticoagulant therapy used to prevent stroke in patients with Atrial fibrillation (AF) may not be as effective in women, 75 years or older, as in men. "Our results suggest that elderly women with AF may need to be targeted for more effective stroke prevention...

2012-05-09 02:26:47

BOSTON, May 9, 2012 /PRNewswire/ -- Today, Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions and the year's premier conference on cardiac arrhythmias, kicks off at the Boston Convention and Exhibition Center with the Opening Plenary session led by Harvard professor, author and head of the Human Nature Lab at Harvard Nicholas Christakis, MD, PhD, MPH. More than 9,000 cardiac arrhythmia professionals from around the world will attend the four-day meeting to hear the...

2012-05-08 09:47:05

Northwestern's Bluhm Cardiovascular Institute is the first in Illinois to perform this innovative procedure Patients with atrial fibrillation (A-fib) who cannot take blood thinners now have an alternative to reduce their risk of stroke, which is five times more common in people with the rhythm disorder. The non-surgical procedure works by tying off the left atrial appendage (LAA), the source of most blood clots leading to stroke in patients with A-fib. Northwestern Medicine® heart...

2012-05-07 10:25:07

Northwestern's Bluhm Cardiovascular Institute is the first in Illinois to perform this innovative procedure CHICAGO, May 7, 2012 /PRNewswire-USNewswire/ -- Patients with atrial fibrillation (A-fib) who cannot take blood thinners now have an alternative to reduce their risk of stroke, which is five times more common in people with the rhythm disorder. The non-surgical procedure works by tying off the left atrial appendage (LAA), the source of most blood clots leading to stroke in patients...

2012-05-07 02:32:37

NATICK, Mass., May 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval and market launch of its INGENIO((TM)) and ADVANTIO((TM)) pacemakers and INVIVE((TM)) cardiac resynchronization therapy pacemakers (CRT-P). The first implant of the INGENIO pacemaker in the U.S. was performed on May 3 by Bruce L. Wilkoff, M.D., Director of Cardiac Pacing and Tachyarrhythmia Devices at the Cleveland Clinic. To access the multi-media...

2012-05-06 23:00:51

EP Europace July 19, 2011 reports multicenter study demonstrates a significant reduction of fluoroscopy (x-ray radiation) using 3D mapping to guide AF catheter ablation. Scottsdale, Arizona (PRWEB) May 06, 2012 When Dr. Renzo Cataldo, a cardiac electrophysiologist (EP) with Arizona Arrhythmia Consultants, one of the premier cardiac electrophysiology groups in Arizona met with a new patient, he was positive he could help him with an advanced AF catheter ablation procedure with excellent...

2012-05-03 02:32:08

RIDGEFIELD, Conn., May 3, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the GLORIA(TM)-AF Registry Program, the largest prospective observational study in non-valvular atrial fibrillation (NVAF) planned at this time. With a goal of enrolling 56,000 patients, the registry aims to understand the long-term use of antithrombotic treatments to reduce the risk of stroke in patients with NVAF. GLORIA-AF will follow newly-diagnosed...

2012-05-02 02:27:55

MORRISVILLE, N.C., May 2, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be included in an oral presentation during an abstract session and two poster presentations at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, May 9-12 in Boston, MA. nContact's Numeris® Coagulation System with VisiTrax® and EPi-Sense(TM) Coagulation System technology integrates suction, perfusion, and...